The DOI matches its Crossref record; 86 of the 88 references it cites were found in a registry or an index; 9 of the 67 sources its claims cite were checked for support.
Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up
Open accessAbstract
Background: Anxiety disorders are highly prevalent and cause substantial economic burden. Blended cognitive-behavioural therapy (bCBT), which integrates Internet-based CBT and face-to-face CBT (ftfCBT), is an attractive and potentially cost-saving treatment alternative to conventional CBT for patients with anxiety disorders in specialised mental health care. However, little is known about the effectiveness of bCBT in routine care. We examined the acceptability, effectiveness and cost-effectiveness of bCBT versus ftfCBT in outpatient specialised care to patients with panic disorder, social anxiety disorder and generalised anxiety disorder. Methods and findings: Patients with anxiety disorders were randomised to bCBT (n = 52) or ftfCBT (n = 62). Acceptability of bCBT and ftfCBT were evaluated by assessing treatment preference, adherence, satisfaction and therapeutic alliance. Costs and effects were assessed at post-treatment and one-year follow-up. Primary outcome measure was the Beck Anxiety Inventory (BAI). Secondary outcomes were depressive symptoms, general psychopathology, work and social adjustment, quality of life and mastery. Incremental cost-effectiveness ratios (ICERs) were computed from societal and healthcare perspectives by calculating the incremental costs per incremental quality-adjusted life year (QALY). No significant differences between bCBT and ftfCBT were found on acceptability or effectiveness measures at post-treatment (Cohen’s d between-group effect size on BAI = 0.15, 95% CI −0.30 to 0.60) or at one-year follow-up (d = −0.38, 95% CI −0.84 to 0.09). The modelled point estimates of societal costs (bCBT €10945, ftfCBT €10937) were higher and modelled point estimates of direct medical costs (bCBT €3748, ftfCBT €3841) were lower in bCBT. The acceptability curves showed that bCBT was expected to be a cost-effective intervention. Results should be carefully interpreted due to the small sample size. Conclusions: bCBT appears an acceptable, clinically effective and potentially cost-saving alternative option for treating patients with anxiety disorders. Trials with larger samples are needed to further investigate cost-effectiveness. Trial registration: Netherlands Trial Register: NTR4912.
Overview
CoChat Summary
## TL;DR
This 15-week randomized controlled trial compared blended CBT (bCBT) with face-to-face CBT (ftfCBT) for panic disorder, social anxiety disorder, and generalized anxiety disorder in Dutch specialized mental health care. bCBT was similarly acceptable and clinically effective as ftfCBT, and it had lower direct medical costs with slightly higher QALYs over 1 year, suggesting cost-effectiveness.
## Key findings
- Sample and follow-up: 114 patients were randomized (bCBT n = 52, ftfCBT n = 62); mean age was 36.3 years and 60.5% were female. Post-treatment data were available for 77/114 (67.5%) and 1-year follow-up data for 74/114 (64.9%).
- Acceptability: Before randomization, 54.4% of patients preferred bCBT over ftfCBT. Treatment adherence was 67.4% completed prescribed sessions in bCBT vs 61.6% in ftfCBT, and treatment completion was 59.6% vs 51.6%, respectively; none of these differences were statistically significant.
- Effectiveness: No significant between-group differences were found for anxiety severity at post-treatment (t = -0.715, p = 0.477) or 1-year follow-up (t = 1.702, p = 0.093). Within-group anxiety effect sizes were d = 0.73 (bCBT) and d = 0.55 (ftfCBT) at post-treatment, and d = 0.50 (bCBT) and d = 1.00 (ftfCBT) at follow-up.
- Costs and QALYs: Over 1 year, direct medical costs were €3758 for bCBT and €3841 for ftfCBT, with a statistically significant difference (mean -83.78, 95% CI -96.96 to -70.61, p < 0.001). QALYs were 0.66 for bCBT and 0.62 for ftfCBT (mean 0.037, 95% CI 0.036 to 0.038, p < 0.001), yielding an ICER of €-2257 per QALY from the healthcare perspective and €219 per QALY from the societal perspective.
## Methods
- Parallel-group randomized controlled trial in outpatient specialized mental health care in the Netherlands, with assessments at baseline, 15 weeks (post-treatment), and 52 weeks (1-year follow-up).
- Included adults with DSM-IV panic disorder, social anxiety disorder, or generalized anxiety disorder; 114 participants were randomized across four sites, with stratified block randomization and no blinding of patients or therapists.
- Primary outcome was anxiety severity on the Beck Anxiety Inventory (BAI); secondary outcomes included depressive symptoms, general psychopathology, mastery, work/social functioning, quality of life, and costs/QALYs. Clinical outcomes were analyzed with linear mixed models under an ITT approach; costs and QALYs were analyzed with generalized linear models and multiple imputation.
## Limitations
- The paper states the sample was smaller than expected: 114 participants were included instead of the intended 156, so only “initial indications” of cost-effectiveness could be explored.
- There was substantial study dropout, with 35.1% missing at 1-year follow-up; this was not considered in the power calculation.
- Participants and therapists could not be blinded to treatment allocation, which the paper says may have affected results.
- Evident from the text: the study was conducted in specialized mental health care in the Netherlands with anxiety disorders only, which limits generalizability beyond this setting and these diagnoses.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
6 Valid · 0 Not valid · 38 Not checked · 69 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“in a recent meta-analysis [12], a large effect size (g = 0.79) was found for anxiety symptom reduction by iCBT as compared with waitlisted controls in samples recruited from the community”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Background
What the sources say
- Supportedcites [12] G Romijn, 2019, Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment, Meta-Analysis. J Med Internet Res source
The Results section 'Open Recruitment Versus Clinical Service Recruitment' (Primary Outcome) states that for studies with waitlist control (WLC) comparators, 'The effect size on anxiety symptom reduction for OR trials was significant and large (g=0.79; P<.001) in favor of iCBT', and Table 2 gives the corresponding subgroup value 0.79 (95% CI 0.71-0.87) across 37 open-recruitment comparisons (2474 respondents). The Methods (Abstract) define open recruitment trials as 'recruitment from the community', matching the claim's community-recruited samples, and the paper itself characterizes 0.79 as a large effect. All qualifiers — iCBT vs waitlisted controls, anxiety symptom reduction, community recruitment, magnitude g=0.79 — are stated in our copy. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“while a small effect size (g = 0.28) was found in the same comparison in routine care populations.”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Background
What the sources say
- Supportedcites [12] G Romijn, 2019, Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment, Meta-Analysis. J Med Internet Res source
Results > Open Recruitment Versus Clinical Service Recruitment > Primary Outcome states that for studies with WLC comparators, CSR trials obtained a small effect size (g=0.28; P=.003) in favor of iCBT, versus g=0.79 for OR trials; Table 2 gives the same figure with 95% CI 0.10-0.47 across 4 clinical-recruitment comparisons (n=446). The paper equates CSR trials with routine care populations (Methods classification of clinical service recruitment via outpatient clinics; Conclusions: 'for patients with anxiety disorders in routine care'), and its own small-effect threshold (0.2 per Statistical Analyses) supports labeling g=0.28 as small. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“iCBT has been found effective for several anxiety disorders [10–13], and there are indications for its cost-effectiveness [14].”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Background
What the sources say
- Not checked yetcites [10] V Olthuis J, 2015, Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults, Cochrane database Syst Rev
- Not checked yetcites [11] CB Adelman, 2014, A meta-analysis of computerized cognitive-behavioral therapy for the treatment of DSM-5 anxiety disorders., J Clin Psychiatry source
- Supportedcites [12] G Romijn, 2019, Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment, Meta-Analysis. J Med Internet Res source
The Introduction (Background) states that iCBT is effective for anxiety disorders compared with a waitlist control. The Results (Overall Effect) report a significant reduction in anxiety symptoms, and the Methods (Interventions and Comparators) include studies targeting multiple anxiety disorders. The cost-effectiveness clause has a separate citation and is not attributed to this source. (LLM, conf=0.92)
- Not checked yetcites [13] PMG Emmelkamp, 2005, Technological innovations in clinical assessment and psychotherapy., Psychother Psychosom source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“bCBT has been found to be better received by both providers and patients than iCBT, because the face-to-face contact in the blended format makes the treatment more personal, better addresses the needs of patients with complex symptomatology, and may help improve adherence rates [15, 19–21].”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Background
What the sources say
- Partly supportedcites [15] N Topooco, 2017, Attitudes towards digital treatment for depression: A European stakeholder survey, Internet Interv sourceExperimental — accuracy not yet measured
Our copy supports the core comparative reception finding: BT was recommended far more often than standalone ICBT (mild 70% vs 47%, moderate 57% vs 16%, severe 27% vs 2%; Results, 'Acceptance of treatments'), and 'the acceptance was considerably higher for BT, and this result was consistent for all stakeholder subgroups' (Discussion, Summary of findings), with ICBT criticised as 'impersonal' and concerns tied to 'the elimination of face-to-face interaction' (Discussion, Result on acceptance of digital treatments). Three parts of the claim are not supported by this source: (1) respondents were organisations/stakeholder groups, not patients — the paper notes 'patient representatives and not actual patients participated in this survey' and that patient organisations showed the least acceptance of ICBT; (2) the causal 'because' is disclaimed, since 'the reasons for the reported difference in the level of acceptance was not directly assessed in this survey'; (3) no adherence benefit of blended format is reported — 'patient adherence' appears only as a 0.6% incentive for standalone ICBT implementation (Table 6), and the idea that BT suits patients with more severe (not 'complex') symptomatology is stated in the Introduction only as 'it has been suggested' citing Kleiboer et al. (2016). (LLM, conf=0.82)
- Partly supportedcites [19] I Titzler, 2018, Barriers and facilitators for the implementation of blended psychotherapy for depression: A qualitative pilot study of therapists’ perspective, Internet Interv sourceExperimental — accuracy not yet measured
Our copy supports the provider half of the claim: the Introduction (passage 3) reports that 'BT was more acceptable as an effective treatment for depression for all severity levels, compared to stand-alone IMIs' among care providers, and the Discussion (passage 7) repeats that BT 'was more accepted than stand-alone IMIs, because the lack of personal contact... was seen as a crucial barrier' — but in both places this is a result the paper reports from Topooco et al. (2017), not its own finding. The patient half is not supported: this is a qualitative study of 12 therapists only (Methods, Design of the trial, passage 6), and patient acceptability appears solely as a hedged 'possible advantage' of blended approaches ('acceptability to patients for whom pure online-based interventions might not be a suitable treatment option'; adherence 'improved... compared to purely online guided interventions', Introduction, passage 8), credited to other works (Ebert et al., 2015; Baumeister et al., 2014; Erbe et al., 2017; Klein et al., 2016). The citing sentence states as an established finding ('has been found... better received by both providers and patients') what our copy offers as provider-side evidence plus a hedged, second-hand patient-side advantage; it also notes limits that cut against the claim (only 55% of providers saw BT suitable for moderate depression, 22% for severe cases; severe depression and comorbidity flagged as contraindications). (LLM, conf=0.78)
- Partly supportedcites [20] R Schuster, 2018, The Advantages and Disadvantages of Online and Blended Therapy: Survey Study Amongst Licensed Psychotherapists in Austria., J Med Internet Res sourceExperimental — accuracy not yet measured
Our copy of Schuster et al. (2018) supports only a qualified provider-side favouring of blended over Web-based format: Results > Overall Differences reports perceived advantages nearly equal (blended 3.61 vs Web-based 3.45; t94=1.89, P=.06, d=0.11) while perceived disadvantages differed strongly to the detriment of Web-based interventions (d=0.81), and the Conclusion states therapists' 'preferences of blended therapy over Web-based interventions seem to be risk-driven'. The Discussion > Principal Findings explicitly qualifies this: 'there was no overall preference nor was there significant difference between both intervention formats' advantages'. The patient half of the claim is not supported at all — the sample was 95 licensed Austrian psychotherapists only (Results > Surveyed Therapists; Methods > Procedure), with no patient ratings, and the stated reasons (more personal face-to-face contact, complex symptomatology, adherence) are not this paper's findings. (LLM, conf=0.78)
- Partly supportedcites [21] D Erbe, 2017, Blending face-to-face and internet-based interventions for the treatment of mental disorders in adults: Systematic review., J Med Internet Res sourceExperimental — accuracy not yet measured
Our copy reports only that blended interventions used to improve delivery of evidence-based treatment in primary care 'has been successful in acceptability and in reducing symptomatology' (Results > Outcome, Integrated Blended Interventions With Internet Focus), and even there it immediately adds that two controlled studies could not show superiority over an active nonblended control group. No passage states a comparative finding that blended CBT is better received than iCBT, and nothing addresses reception by providers; the closest patient-side material is the qualitative study on motivation to persist with iCBT through face-to-face support (Results > Outcome) and the Introduction's note that stand-alone Internet treatments are regarded as low-threshold options for milder cases while face-to-face is the option of choice for more severe symptoms. The 'both providers and patients' and 'better than iCBT' elements of the claim are therefore not supported by this source. (LLM, conf=0.65)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, participants in our study appear to be a clinically representative sample, in view of the large proportion of patients with comorbid disorders, lower education levels and severe anxiety symptoms at baseline, in comparison with self-referred samples recruited from the community [12].”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Discussion
What the sources say
- Partly supportedcites [12] G Romijn, 2019, Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment, Meta-Analysis. J Med Internet Res sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
39 more claims
Create a free account to see all 113 claims and to verify the 58 references still open.
- Probably not a substantial claim. 47
- It may state two separate claims as one. 38
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The bCBT appears to be an acceptable, clinically effective, and cost-effective option for treating depression and anxiety disorders [27-32].”
From Barriers to and Facilitators of a Blended Cognitive Behavioral Therapy Program for Depression and Anxiety Based on Experiences of University Students: Qualitative Interview Study (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The non-completion rate is high, but inferior to that found in other studies on blended interventions (Rasing et al., 2021; Romijn et al., 2021) and comparable to that of other studies of both computerized and face-to-face treatments for depression (De Haan et al., 2013; Kaltenthaler et al., 2008).”
From Feasibility, acceptability, and preliminary efficacy of a blended transdiagnostic group CBT for the treatment of emotional disorders (2025) · cites this paper as Romijn et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“randomized controlled trials (RCTs) have shown the efficacy of blended treatments for depression (e.g., Kemmeren et al., 2023) and for anxiety (e.g., Romijn et al., 2021), and a recent meta-analysis has found blended interventions to be more effective or non-inferior to treatment-as-usual for depression (Nunes-Zlotkowski et al., 2024).”
From Feasibility, acceptability, and preliminary efficacy of a blended transdiagnostic group CBT for the treatment of emotional disorders (2025) · cites this paper as Romijn et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“In addition to prior research showing that bCBT is effective in reducing symptomology [29-32], the results of our qualitative investigation further indicate that the use of the app along with face-to-face sessions also seems to be associated with positive feelings regarding the therapy process among students.”
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“χ2 (2) = 4.84, p = 0.028”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Results > Study sample and attrition
Reported p = .028 · recomputed p = .089
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“χ2 (1) = 0.78, p = 0.781”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Results > Study sample and attrition
Reported p = .781 · recomputed p = .377
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upχ²(2) = 4.84reported p = .028 · recomputed p = .089The two fall on opposite sides of .05
“χ2 (2) = 4.84, p = .028”
- Doesn’t add upχ²(1) = 0.78reported p = .781 · recomputed p = .377
“χ2 (1) = 0.78, p = .781”
- Consistentχ²(1) = 0.23reported p = .629 · recomputed p = .632
“χ2 (1) = 0.23, p = .629”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Results > Acceptability
“Queried prior to randomisation, patients expressed a slight preference for bCBT (54.4%) over ftfCBT (45.6%).”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Discussion
“Over half (54.9%) of the participants would have preferred to start with bCBT above ftfCBT.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Results > Cost-effectiveness
“yielded average direct medical costs of €3758 for bCBT and €3841 for ftfCBT over the one-year study period.”
§ Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up > Abstract > Methods and findings
“The modelled point estimates of societal costs (bCBT €10945, ftfCBT €10937) were higher and modelled point estimates of direct medical costs (bCBT €3748, ftfCBT €3841) were lower in bCBT.”
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736 · cited 1×
“Although patients in both groups exhibited improvement on these scores at post-treatment and follow-up, the scores remained relatively low in comparison with those in the general healthy population [47, 71].”
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696 · cited 1×
“Presence and severity of depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II) [42, 43], which has highly acceptable psychometric properties [42].”
(1998) · PubMed · Cited by 10,216
SUS: A 'Quick and Dirty' Usability Scale
(1996) · Usability Evaluation In Industry · doi:10.1201/9781498710411-35 · Cited by 8,989
Pearlin, L. I., & Schooler, C. (1978) · Journal of Health and Social Behavior · doi:10.2307/2136319 · Cited by 7,791 · cited 1×
“The five-item version of the Mastery Scale [46] was administered to assess perceived control of a person’s own life; it is a psychometrically valid instrument [46].”
Pearlin, L. I., & Schooler, C. (1978) · PubMed · Cited by 6,764
Research works printed but not linked: 10
- NICE, 2011, Generalised anxiety disorder and panic disorder in adults., Natl Inst Heal Clin Excell
- National Institute for Health and Care Excellence, 2013, Social anxiety disorder: recognition, assessment and treatment., Clinical guideline 159
- H Riper, 2013, Preventie & eMental-health. Onderzoek dat leidt, technologie die verleidt, preventie die bereikt en beklijft., Kennissynthese 2013 in opdracht van ZonMw. Amsterdam
- MB First, 2002, Structured Clinical Interview for DSM-IV-TR Axis I Disorders.
- IM Van Vliet, 2007, Het Mini Internationaal Neuropsychiatrisch Interview (MINI): Een kort gestructureerd diagnostisch psychiatrisch interview voor DSM-IV-en ICD-10-stoornissen., Tijdschr Psychiatr, 49, 393
- W. Van der Does, 2002, De Nederlandse versie van de Beck Depression Inventory-2nd edition.
- EDE Beurs, 2006, De Brief Symptom Inventory., Maandbl Geestelijke Volksgezond, 61, 120
- L Hakkaart-van Roijen, 2015, Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg., Zorginstituut Ned.
- 1990, EuroQol—a new facility for the measurement of health-related quality of life, Health Policy (New York), 16, 199, 10.1016/0168-8510(90)90421-9 · DOI · Paper page
- L Hakkaart-van Roijen, 2016, Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg., Dutch Natl Heal Care Inst, 1
Cited by
Mol, M., van Genugten, C., Dozeman, E., van Schaik, D. J. F., Draisma, S., Riper, H., & Smit, J. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010091 · Cited by 61
Self-citation(2024) · doi:10.2196/49660 · Cited by 45
Kruse, C. S., Betancourt, J., Gonzales, M., Dickerson, K., & Neer, M. (2022) · JMIR Mental Health · doi:10.2196/42301 · Cited by 33
“When mHealth was used as the intervention, a reduction in both depression and anxiety was reported [26,27,29,30,32,33,35,36,38,39,41,43,45-50, 53, 55”
Owusu, J. T., Wang, P., Wickham, R. E., Varra, A. A., Chen, C., & Lungu, A. (2022) · Telemedicine and e-Health · doi:10.1089/tmj.2021.0590 · Cited by 24
Atik, E., Stricker, J., Schückes, M., & Pittig, A. (2022) · doi:10.2196/preprints.44742 · Cited by 23
Metadata
- Authors
- Romijn, G., Batelaan, N., Koning, J., van Balkom, A., de Leeuw, A., Benning, F., Hakkaart van Roijen, L., & Riper, H.
- Affiliations
- GGz Breburg (NL)
- Amsterdam Public Health (NL)
- Erasmus University Rotterdam (NL)
- Corresponding author
- Romijn, Geke
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-11-12
- Volume
- 16
- Issue
- 11
- Pages
- e0259493
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8589191
- OpenAlex
- W3213316242
- Cited by
- 46
- References
- 88
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 11 · 2023: 8 · 2022: 4 · 2021: 1
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
- VU Research Portal (publishedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- ZonMw (837002505)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Keywords
- internet-based CBT, anxiety disorders, panic disorder, social anxiety disorder, generalized anxiety disorder, cost-effectiveness, acceptability, outpatient care, quality-adjusted life years, medication adherence, therapeutic relationship, depressive symptoms, quality of life, work and social adjustment, mastery, social costs, health care costs
- MeSH terms
- Adult, Anxiety Disorders, Cost-Benefit Analysis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Cognitive Behavioral Therapy, Telemedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up. https://app.cochat.ai/papers/10.1371/journal.pone.0259493
- The paper
- Romijn, G., Batelaan, N., Koning, J., van Balkom, A., de Leeuw, A., Benning, F., Hakkaart van Roijen, L., & Riper, H. (2021). Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up. PLOS ONE. https://doi.org/10.1371/journal.pone.0259493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.